Form 4: ACM Research CFO Exercises Options, Sells Shares

ACM Research's CFO and Treasurer, Mark McKechnie, exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 trading plan.

Summary

• Mark McKechnie, Chief Financial Officer and Treasurer of ACM Research, Inc. (ACMR), engaged in multiple transactions on March 12, 2026.
• He exercised stock options to acquire 60,000 shares of Class A Common Stock at an exercise price of $13.89 per share.
• He also exercised stock options to acquire an additional 38,551 shares of Class A Common Stock at an exercise price of $19.49 per share.
• Following these exercises, he sold a total of 11,910 shares at a weighted average price of $44.89, 47,108 shares at $45.74, and 982 shares at $46.55.
• Additionally, he sold 8,639 shares at a weighted average price of $44.94, 29,348 shares at $45.74, and 564 shares at $46.57.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025.
• After these transactions, McKechnie beneficially owns 900 shares directly from the first set of transactions and 900 shares directly from the second set of transactions, along with remaining derivative securities (options) for 240,000 and 61,449 shares respectively.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions are routine exercises and sales under a pre-established 10b5-1 plan, which is common for executive compensation and personal financial management and does not signal a change in company prospects.

Positives

• The executive exercised stock options at significantly lower prices ($13.89 and $19.49) compared to the market prices at which the shares were sold (ranging from $44.37 to $46.59), indicating a profitable transaction for the insider.
• The transactions were executed under a Rule 10b5-1 trading plan, which suggests a pre-planned and systematic approach to managing executive compensation and personal finances, rather than a reaction to immediate market conditions or non-public information.

Negatives

• The sale of a substantial number of shares by a key executive, even if pre-planned, could be perceived by some investors as a lack of confidence, although the 10b5-1 plan mitigates this concern.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Mark McKechnie is identified as the Chief Financial Officer and Treasurer of ACM Research, Inc.

Industry Context

StockSavvy.ai notes that routine insider transactions under Rule 10b5-1 plans are common for executives managing personal finances and diversifying holdings, and typically do not reflect a change in company fundamentals or outlook. Such plans are widely used across industries to allow insiders to sell shares without concerns about insider trading allegations.

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation and personal financial management. While there is a slight increase in shares outstanding from option exercises, the overall impact on existing shareholders is generally considered minimal given the pre-planned nature of the sales.

Key Dates

Recommendation

The transactions represent routine executive compensation management through a pre-planned 10b5-1 trading plan, not an indication of a change in company fundamentals. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an investment thesis.

Keywords

ACM Research, ACMR, Form 4, insider trading, stock options, share sale, Mark McKechnie, CFO, 10b5-1 plan, executive compensation